{"chebi_id":"40237","chebi_name":"sitagliptin","chebi_synonyms":["(3R)-3-amino-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-a]pyrazin-7(8H)-yl]-4-(2,4,5-trifluorophenyl)butan-1-one","(2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE","MK-0431","sitagliptina","sitagliptinum","sitagliptine"],"diffprof_id_observed":["MTBLS1792_0001_00000018","MTBLS4820_0002_00000001","MTBLS5828_0002_00000001"],"diffprof_id_var_observed":["MTBLS4820_0002_00000001"],"inchikey":"MFFMDFFZMYYVKS-SECBINFHSA-N","inn_name":"sitagliptine","iupac_name":"(3<i>R</i>)-3-amino-1-[3-(trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-<em>a</em>]pyrazin-7(8<em>H</em>)-yl]-4-(2,4,5-trifluorophenyl)butan-1-one","num_study_observed":3,"reactome_ids":["R-HSA-2980736","R-HSA-381771","R-HSA-392499","R-HSA-400508"],"reactome_names":["Peptide hormone metabolism","Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)","Metabolism of proteins","Incretin synthesis, secretion, and inactivation"],"study_id_observed":["MTBLS1792","MTBLS4820","MTBLS5828"],"study_id_var_observed":["MTBLS4820"],"synonym_name":"(2R)-4-OXO-4-[3-(TRIFLUOROMETHYL)-5,6-DIHYDRO[1,2,4]TRIAZOLO[4,3-A]PYRAZIN-7(8H)-YL]-1-(2,4,5-TRIFLUOROPHENYL)BUTAN-2-AMINE"}